PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS
Abstract
Authors
A. Karpes Matusevich R. Rasu L. Lal C. Wenyaw J.M. Swint S.B. Cantor M.E. Suarez-Almazor M.A. Lopez-Olivo